Comment on FR Doc # 2026-12989, NRC-2025-1303-0001, from Anonymous

Please explain the rationale for applying the SMR dose limits at site boundry to the operating fleet. The technology is different, therefore the risk is higher. Or is this another signal the agency is in regulatory capture?